Filing Details
- Accession Number:
- 0001209191-15-082280
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-25 17:27:04
- Reporting Period:
- 2015-11-23
- Filing Date:
- 2015-11-25
- Accepted Time:
- 2015-11-25 17:27:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189184 | Jr F Thomas Kearns | C/O Fibrogen, Inc. 409 Illinois St. San Francsico CA 94158 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-11-23 | 3,900 | $28.02 | 173,836 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-11-24 | 1,000 | $28.46 | 172,836 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-11-24 | 2,900 | $29.19 | 169,936 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 110,000 | Indirect | By Trust |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $27.49 to $28.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $28.07 to $28.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $29.00 to $29.62. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.